Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Andria Langenberg, MD
Anesiva, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Miami Skin Research
Miami, Florida, United States
- Minnesota Clinical Study Center
Fridley, Minnesota, United States
- Mount Sinai School of Medicine
New York, New York, United States
- Helendale Dermatology & Medical Spa, Llp
Rochester, New York, United States
- Oregon Health & Science University, Department of Dermatology
Portland, Oregon, United States
- Derm Research, Inc.
Austin, Texas, United States
- Center for Clinical Studies
Houston, Texas, United States
- Center for Clinical Studies
South Houston, Texas, United States
- Madison Skin & Research, Inc.
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2005
- Primary completion
- —
- Completion
- 30 Nov 2005
- Last update posted
- 19 Nov 2008
- Registered enrollment
- 75
- Registry id
- NCT00125333
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.